Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.4779
Delayed Data
As of Feb 05
 +0.0079 / +1.68%
Today’s Change
0.40
Today|||52-Week Range
0.90
-29.98%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.47
Today’s open0.46
Day’s range0.45 - 0.49
Volume70,597
Average volume (3 months)358,658
Market cap$21.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio1.4
Price/Sales1.55
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...-0.07-8.84%
PRPHProPhase Labs Inc-0.02-2.02%
THLDThreshold Pharmaceut...-0.00-0.45%
--Luckycom Inc0.000.00%
Data as of 3:59pm ET, 02/05/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

Partner Offers